全文获取类型
收费全文 | 3165824篇 |
免费 | 252882篇 |
国内免费 | 5410篇 |
专业分类
耳鼻咽喉 | 45399篇 |
儿科学 | 99886篇 |
妇产科学 | 86281篇 |
基础医学 | 453751篇 |
口腔科学 | 91726篇 |
临床医学 | 293592篇 |
内科学 | 610956篇 |
皮肤病学 | 65961篇 |
神经病学 | 263198篇 |
特种医学 | 124573篇 |
外国民族医学 | 1104篇 |
外科学 | 469881篇 |
综合类 | 73676篇 |
现状与发展 | 4篇 |
一般理论 | 1435篇 |
预防医学 | 260142篇 |
眼科学 | 75033篇 |
药学 | 236893篇 |
10篇 | |
中国医学 | 5588篇 |
肿瘤学 | 165027篇 |
出版年
2018年 | 32863篇 |
2017年 | 25311篇 |
2016年 | 27901篇 |
2015年 | 31719篇 |
2014年 | 45201篇 |
2013年 | 69056篇 |
2012年 | 93217篇 |
2011年 | 98889篇 |
2010年 | 57996篇 |
2009年 | 55612篇 |
2008年 | 93836篇 |
2007年 | 100109篇 |
2006年 | 100471篇 |
2005年 | 98103篇 |
2004年 | 94355篇 |
2003年 | 90753篇 |
2002年 | 89254篇 |
2001年 | 142692篇 |
2000年 | 147071篇 |
1999年 | 124011篇 |
1998年 | 34179篇 |
1997年 | 30754篇 |
1996年 | 30777篇 |
1995年 | 31478篇 |
1994年 | 29633篇 |
1993年 | 27709篇 |
1992年 | 100778篇 |
1991年 | 98142篇 |
1990年 | 94867篇 |
1989年 | 91515篇 |
1988年 | 85093篇 |
1987年 | 83654篇 |
1986年 | 79532篇 |
1985年 | 75844篇 |
1984年 | 57575篇 |
1983年 | 49652篇 |
1982年 | 30007篇 |
1981年 | 26837篇 |
1979年 | 54508篇 |
1978年 | 38869篇 |
1977年 | 32649篇 |
1976年 | 30565篇 |
1975年 | 32570篇 |
1974年 | 40011篇 |
1973年 | 38472篇 |
1972年 | 36326篇 |
1971年 | 33702篇 |
1970年 | 31671篇 |
1969年 | 29636篇 |
1968年 | 27198篇 |
排序方式: 共有10000条查询结果,搜索用时 93 毫秒
11.
Osama Y Safdar Rana M Baghdadi Sereen A Alahmadi Bana E Fakieh Amaal M Algaydi 《World Journal of Clinical Pediatrics》2022,11(1):14-26
Whether the underlying mutations are homozygous, heterozygous, or co-inherited with other hemoglobinopathies, sickle cell disease is known to afflict the kidneys, leading to the clinical entity known as sickle cell nephropathy (SCN). Although common, SCN remains diagnostically elusive. Conventional studies performed in the context of renal disorders often fail to detect early stage SCN. This makes the quest for early diagnosis and treatment more challenging, and it increases the burden of chronic kidney disease-related morbidity among patients. Novel diagnostic tools have been employed to overcome this limitation. In this study, we discuss various biomarkers of SCN, including those employed in clinical practice and others recently identified in experimental settings, such as markers of vascular injury, endothelial dysfunction, tubulo-glomerular damage, and oxidative stress. These include kidney injury molecule-1, monocyte chemoattractant protein-1, N-acetyl-B-D-glucosaminidase, ceruloplasmin, orosomucoid, nephrin, and cation channels, among others. Furthermore, we explore the potential of novel biomarkers for refining diagnostic and therapeutic approaches and describe some obstacles that still need to be overcome. We highlight the importance of a collaborative approach to standardize the use of promising new biomarkers. Finally, we outline the limitations of conventional markers of renal damage as extensions of the pathogenic process occurring at the level of the organ and its functional subunits, with a discussion of the expected pattern of clinical and biochemical progression among patients with SCN. 相似文献
12.
13.
14.
Die Anaesthesiologie - 相似文献
15.
16.
17.
Matthias Knefel PhD Elisabeth L. Zeilinger PhD Simone Lubowitzki PhD Katharina Krammer MSc Matthias Unseld MD Rupert Bartsch MD Thorsten Fuereder MD Ulrich Jäger MD Barbara Kiesewetter MD Maria Krauth MD Markus Raderer MD Philipp B. Staber MD Peter Valent MD Alexander Gaiger MD 《Cancer》2023,129(21):3466-3475
Background
Survival in cancer patients is associated with a multitude of biological, social, and psychological factors. Although it is well established that all these factors add to overall mortality, it is not well understood how the predictive power of these parameters changes in a comprehensive model and over time.Methods
Patients who attended the authors’ outpatient clinic were invited to participate. The authors followed 5180 mixed cancer patients (51.1% female; mean age, 59.1 years [SD = 13.8]) for up to 16 years and analyzed biological (age, sex, cancer site, anemia), psychological (anxiety, depression), and social variables (marital status, education, employment status) potentially predicting overall survival in a Cox proportional hazards model.Results
The median survival time for the entire sample was 4.3 years (95% confidence interval, 4.0–4.7). The overall survival probabilities for 1 and 10 years were 76.8% and 38.0%, respectively. Following an empirical approach, the authors split the time interval into five periods: acute, subacute, short-term, medium-term, and long-term. A complex pattern of variables predicted overall survival differently in the five periods. Biological parameters were important throughout most of the time, social parameters were either time-independent predictors or tended to be more important in the longer term. Of the psychological parameters, only depression was a significant predictor and lost its predictive power in the long-term.Conclusions
The findings of this study allow the development of comprehensive patient-specific models of risk and resilience factors addressing biopsychosocial needs of cancer patients, paving the way for a personalized treatment plan that goes beyond biomedical cancer care. 相似文献18.
19.
Inflammopharmacology - The inflammatory process is a biological response of the organism to remove injurious stimuli and initiate homeostasis. It has been recognized as a key player in the most... 相似文献